Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


  • BS  Sun Yat-sen University 2020
  • MSc Imperial College London 2021

Junyu (Jerry) Huang

DPhil student

Development of novel DMD RNA-based therapeutics and the discovery of RNA Biomarkers of neuromuscular disorders

DMD is a fatal X-linked recessive neuromuscular disorder caused by mutations in the dystrophin gene. Patients with DMD develop a progressive muscle degeneration and weakness that results in loss of ambulation around 12 years of age leading eventually to premature death due to respiratory or heart muscle failure in their 20’s.

Junyu(Jerry) Huang joined Thomas Roberts team as a Dphil student in June 2023 working on the development of novel DMD RNA-based therapeutics and the discovery of RNA Biomarkers of neuromuscular disorders.

Jerry studied at Imperial College London for his master degree in Applied Biosciences and Biotechnology. There he investigated the effect of viral dsRNA on Treg differentiation under the supervision of Prof Masahiro Ono. Before that, he studied at Sun Yat-sen University in Biotechnology and received experimental skills training supervised by Professor Qing Zhang. During the period, he have won the golden medal in The International Genetically Engineered Machine Competition (iGEM) by designing a targeted cancer therapy platform using endogenous miRNA profile of cancer cells as the target.


Follow me on Twitter